This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Tokyo Medical University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Tomohiro Umezu: Innovator in Nucleic Acid Delivery
Introduction
Tomohiro Umezu is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid delivery systems. His innovative work focuses on developing novel carriers for introducing nucleic acids into cells, which has important implications for gene therapy and medical treatments.
Latest Patents
Umezu holds a patent for a "Nucleic acid carrier and method for administering nucleic acid." This invention provides a novel carrier for introducing nucleic acids, such as siRNA, into cells. The carrier includes vesicles derived from plants in the family Malpighiaceae, with a preference for those derived from acerola. The method involves forming a conjugate of the nucleic acid carrier and the nucleic acid, followed by administering this conjugate to achieve effective delivery.
Career Highlights
Tomohiro Umezu is affiliated with Tokyo Medical University, where he continues to advance his research in biotechnology. His work has garnered attention for its potential to enhance the efficacy of nucleic acid therapies. Umezu's innovative approach to using plant-derived vesicles represents a significant step forward in the field.
Collaborations
Umezu collaborates with notable colleagues, including Masakatsu Takanashi and Shin-ichiro Ohno. Their combined expertise contributes to the advancement of research in nucleic acid delivery systems.
Conclusion
Tomohiro Umezu's contributions to the field of biotechnology, particularly through his patented nucleic acid carrier, highlight his role as an innovator in medical science. His work promises to pave the way for more effective gene therapies in the future.